Cargando…
A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
BACKGROUND: Lower-grade gliomas (LGGs) are characterized by remarkable genetic heterogeneity and different clinical outcomes. Classification of LGGs is improved by the development of molecular stratification markers including IDH mutation and 1p/19q chromosomal integrity, which are used as a hallmar...
Autores principales: | Wu, Wei, Wang, Yichang, Xiang, Jianyang, Li, Xiaodong, Wahafu, Alafate, Yu, Xiao, Bai, Xiaobin, Yan, Ge, Wang, Chunbao, Wang, Ning, Du, Changwang, Xie, Wanfu, Wang, Maode, Wang, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133344/ https://www.ncbi.nlm.nih.gov/pubmed/35646656 http://dx.doi.org/10.3389/fonc.2022.729002 |
Ejemplares similares
-
FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling
por: Wang, Yichang, et al.
Publicado: (2021) -
Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020) -
Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas
por: Wu, Wei, et al.
Publicado: (2021) -
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
por: Xiang, Jianyang, et al.
Publicado: (2022) -
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
por: Alafate, Wahafu, et al.
Publicado: (2020)